首页 > 最新文献

Current Alzheimer research最新文献

英文 中文
Is the Alzheimer's Disease Assessment Scale-Cognitive Subscale useful in screening for mild cognitive impairment and Alzheimer's disease? A systematic review. 阿尔茨海默病评估量表-认知亚量表在轻度认知障碍和阿尔茨海默病筛查中有用吗?系统回顾。
IF 2.1 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2022-04-04 DOI: 10.2174/1567205019666220404104854
Seong-Hi Park, Kuem-Sun Han
BACKGROUNDMild cognitive impairment (MCI) and Alzheimer's disease (AD) are screened to distinguish whether cognitive decline in older adults is attributed to pathological causes rather than normal aging.OBJECTIVEThe purpose of this review was to analyze the diagnostic performance of the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in screening for MCI and AD.METHODSElectronic searches were performed on MEDLINE, EMBASE, CINAHL, and PsycArticles databases using the following keywords: dementia and ADAS-Cog. The Quality Assessment of Diagnostic Accuracy Studies-2 was used to checked the risk of bias in the diagnostic studies.RESULTSWe reviewed 14 studies, including 3,875 patients who met the selection criteria. In 2,624 MCI patients from nine studies, the pooled sensitivity of ADAS-Cog was 0.80 (95% confidence interval [CI], 0.68-0.88), the pooled specificity was 0.84 (95% CI, 0.75-0.90), and the area under the curve of summary receiver-operating characteristic curves (SROC AUC) was 0.89 (SE = 0.03). In 2,517 AD patients from 10 studies, the pooled sensitivity and pooled specificity were 0.91 (95% CI, 0.86-0.95) and 0.93 (95% CI, 0.88-0.95) respectively, and the sROC AUC was 0.97 (SE = 0.01). Although sub-analyzed according to age and years of education, there was no significant difference in the predictive validity of the ADAS-Cog.CONCLUSIONThe ADAS-Cog has high predictive validity as a screening tool in both MCI and AD, but has better diagnostic performance in patients with AD. When early screening for AD is desired, ADAS-Cog is a first-stage screener that can be initially employed.
背景:对轻度认知障碍(MCI)和阿尔茨海默病(AD)进行筛查,以区分老年人的认知能力下降是否归因于病理原因而不是正常衰老。目的分析阿尔茨海默病评估量表-认知子量表(ADAS-Cog)在MCI和AD筛查中的诊断效果。方法在MEDLINE、EMBASE、CINAHL和PsycArticles数据库中进行电子检索,检索关键词为痴呆和ADAS-Cog。诊断准确性研究质量评估-2用于检查诊断研究的偏倚风险。结果我们回顾了14项研究,包括3875名符合选择标准的患者。在9项研究的2,624例MCI患者中,ADAS-Cog的合并敏感性为0.80(95%可信区间[CI], 0.68 ~ 0.88),合并特异性为0.84 (95% CI, 0.75 ~ 0.90),总接受者-工作特征曲线曲线下面积(SROC AUC)为0.89 (SE = 0.03)。在10项研究的2517例AD患者中,合并敏感性和合并特异性分别为0.91 (95% CI, 0.86-0.95)和0.93 (95% CI, 0.88-0.95), sROC AUC为0.97 (SE = 0.01)。虽然根据年龄和受教育年限进行了亚分析,但ADAS-Cog的预测效度没有显著差异。结论ADAS-Cog作为MCI和AD的筛查工具具有较高的预测效度,但对AD患者的诊断效果更好。当需要对AD进行早期筛查时,ADAS-Cog是一种可初始使用的第一阶段筛查方法。
{"title":"Is the Alzheimer's Disease Assessment Scale-Cognitive Subscale useful in screening for mild cognitive impairment and Alzheimer's disease? A systematic review.","authors":"Seong-Hi Park, Kuem-Sun Han","doi":"10.2174/1567205019666220404104854","DOIUrl":"https://doi.org/10.2174/1567205019666220404104854","url":null,"abstract":"BACKGROUND\u0000Mild cognitive impairment (MCI) and Alzheimer's disease (AD) are screened to distinguish whether cognitive decline in older adults is attributed to pathological causes rather than normal aging.\u0000\u0000\u0000OBJECTIVE\u0000The purpose of this review was to analyze the diagnostic performance of the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in screening for MCI and AD.\u0000\u0000\u0000METHODS\u0000Electronic searches were performed on MEDLINE, EMBASE, CINAHL, and PsycArticles databases using the following keywords: dementia and ADAS-Cog. The Quality Assessment of Diagnostic Accuracy Studies-2 was used to checked the risk of bias in the diagnostic studies.\u0000\u0000\u0000RESULTS\u0000We reviewed 14 studies, including 3,875 patients who met the selection criteria. In 2,624 MCI patients from nine studies, the pooled sensitivity of ADAS-Cog was 0.80 (95% confidence interval [CI], 0.68-0.88), the pooled specificity was 0.84 (95% CI, 0.75-0.90), and the area under the curve of summary receiver-operating characteristic curves (SROC AUC) was 0.89 (SE = 0.03). In 2,517 AD patients from 10 studies, the pooled sensitivity and pooled specificity were 0.91 (95% CI, 0.86-0.95) and 0.93 (95% CI, 0.88-0.95) respectively, and the sROC AUC was 0.97 (SE = 0.01). Although sub-analyzed according to age and years of education, there was no significant difference in the predictive validity of the ADAS-Cog.\u0000\u0000\u0000CONCLUSION\u0000The ADAS-Cog has high predictive validity as a screening tool in both MCI and AD, but has better diagnostic performance in patients with AD. When early screening for AD is desired, ADAS-Cog is a first-stage screener that can be initially employed.","PeriodicalId":10810,"journal":{"name":"Current Alzheimer research","volume":"1 1","pages":""},"PeriodicalIF":2.1,"publicationDate":"2022-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41956630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Blood Biomarkers Predict Future Cognitive Decline after Military-Related Traumatic Brain Injury. 血液生物标志物预测与军事有关的创伤性脑损伤后未来的认知能力下降。
IF 2.1 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2022-03-30 DOI: 10.2174/1567205019666220330144432
S. Lippa, J. Gill, T. Brickell, Vivian A. Guedes, L. French, R. Lange
BACKGROUNDTraumatic brain injury (TBI) has been associated with increased likelihood of late-life dementia; however, the mechanisms driving this relationship are elusive. Blood-based biomarkers may provide insight into these mechanisms and serve as useful prognostic indicators of cognitive recovery or decline following a TBI.OBJECTIVEThe aim of this study was to examine blood biomarkers within one year of TBI and explore their relationship with cognitive decline.METHODSService members and veterans (n=224) without injury (n=77), or with history of bodily injury (n=37), uncomplicated mild TBI (n=55), or more severe TBI (n=55), underwent a blood draw and neuropsychological assessment within one year of their injury as part of a case-control study. A subsample (n=87) completed follow-up cognitive assessment.RESULTSIn the more severe TBI group, baseline glial fibrillary acidic protein (p=.008) and ubiquitin C-terminal hydrolase-L1 (p=.026) were associated with processing speed at baseline, and baseline ubiquitin C-terminal hydrolase-L1 predicted change in immediate (R2Δ=.244, p=.005) and delayed memory (R2Δ=.390, p=.003) over time. In the mild TBI group, higher baseline tau predicted greater negative change in perceptual reasoning (R2Δ=.188, p=.033) and executive functioning (R2Δ=.298, p=.007); higher baseline neurofilament light predicted greater negative change in perceptual reasoning (R2Δ=.211, p=.012).CONCLUSIONBaseline ubiquitin C-terminal hydrolase-L1 strongly predicted memory decline in the more severe TBI group, while tau and neurofilament light strongly predicted decline in the mild TBI group. A panel including these biomarkers could be particularly helpful in identifying those at risk for future cognitive decline following TBI.
背景:创伤性脑损伤(TBI)与老年痴呆的可能性增加有关;然而,驱动这种关系的机制是难以捉摸的。基于血液的生物标记物可能为这些机制提供深入的见解,并作为脑外伤后认知恢复或衰退的有用预后指标。目的:本研究旨在检测脑外伤患者一年内的血液生物标志物,并探讨其与认知能力下降的关系。方法224名无外伤(n=77)、有身体外伤史(n=37)、无并发症的轻度TBI (n=55)或较严重的TBI (n=55)的服役人员和退伍军人(n=224)在受伤后一年内接受抽血和神经心理学评估,作为病例对照研究的一部分。一个子样本(n=87)完成了后续认知评估。结果在较严重的TBI组,基线胶质纤维酸性蛋白(p= 0.008)和泛素c末端水解酶- l1 (p= 0.026)与基线处理速度相关,基线泛素c末端水解酶- l1预测即时变化(R2Δ= 0.026)。244, p=.005)和延迟内存(R2Δ=. 005)。390, p=.003)。在轻度TBI组中,较高的基线tau预示着知觉推理的更大的负面变化(R2Δ=。188, p= 0.033)和执行功能(R2Δ= 0.033)。298年,p = .007);基线神经丝光越高,感知推理的负面变化越大(R2Δ=。211年,p = .012)。结论基线泛素c端水解酶- l1能预测较重度TBI组的记忆衰退,而tau和神经丝光能预测轻度TBI组的记忆衰退。一个包括这些生物标记物的小组可能特别有助于识别那些在TBI后有认知能力下降风险的人。
{"title":"Blood Biomarkers Predict Future Cognitive Decline after Military-Related Traumatic Brain Injury.","authors":"S. Lippa, J. Gill, T. Brickell, Vivian A. Guedes, L. French, R. Lange","doi":"10.2174/1567205019666220330144432","DOIUrl":"https://doi.org/10.2174/1567205019666220330144432","url":null,"abstract":"BACKGROUND\u0000Traumatic brain injury (TBI) has been associated with increased likelihood of late-life dementia; however, the mechanisms driving this relationship are elusive. Blood-based biomarkers may provide insight into these mechanisms and serve as useful prognostic indicators of cognitive recovery or decline following a TBI.\u0000\u0000\u0000OBJECTIVE\u0000The aim of this study was to examine blood biomarkers within one year of TBI and explore their relationship with cognitive decline.\u0000\u0000\u0000METHODS\u0000Service members and veterans (n=224) without injury (n=77), or with history of bodily injury (n=37), uncomplicated mild TBI (n=55), or more severe TBI (n=55), underwent a blood draw and neuropsychological assessment within one year of their injury as part of a case-control study. A subsample (n=87) completed follow-up cognitive assessment.\u0000\u0000\u0000RESULTS\u0000In the more severe TBI group, baseline glial fibrillary acidic protein (p=.008) and ubiquitin C-terminal hydrolase-L1 (p=.026) were associated with processing speed at baseline, and baseline ubiquitin C-terminal hydrolase-L1 predicted change in immediate (R2Δ=.244, p=.005) and delayed memory (R2Δ=.390, p=.003) over time. In the mild TBI group, higher baseline tau predicted greater negative change in perceptual reasoning (R2Δ=.188, p=.033) and executive functioning (R2Δ=.298, p=.007); higher baseline neurofilament light predicted greater negative change in perceptual reasoning (R2Δ=.211, p=.012).\u0000\u0000\u0000CONCLUSION\u0000Baseline ubiquitin C-terminal hydrolase-L1 strongly predicted memory decline in the more severe TBI group, while tau and neurofilament light strongly predicted decline in the mild TBI group. A panel including these biomarkers could be particularly helpful in identifying those at risk for future cognitive decline following TBI.","PeriodicalId":10810,"journal":{"name":"Current Alzheimer research","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2022-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44681215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Effects of supplementation with probiotics in experimental models of Alzheimer's Disease: a systematic review of animal experiments. 补充益生菌对阿尔茨海默病实验模型的影响:动物实验的系统综述。
IF 2.1 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2022-03-18 DOI: 10.2174/1567205019666220318092003
F. Neta, Francisco Emílio Simplício de Souza, André Lima Batista, Francisco Irochima Pinheiro, R. Cobucci, F. Guzen
BACKGROUNDConditions along the brain-gut-microbiota (BGM) axis can significantly contribute to the pathogenesis of Alzheimer's disease (AD). Evidence from animal studies indicates a role for probiotics in regulating mood, cognition, and stress response via the BGM axis. However, the effect of probiotics on AD needs to be better clarified in preclinical and clinical studies.METHODWe prepared this systematic review according to PRISMA. PubMed, Web of Science, Embase, and Virtual Health Library (VHL) were searched for original articles concerning the effects of probiotics in experimental AD.RESULTSResults were presented as a narrative synthesis according to the Synthesis Without Meta-analysis (SWiM) Guideline.Seventeen studies met the inclusion criteria. The results showed significant effects in the experimental models of AD treated with probiotics alone or in mixture form due to expressive improvements in cognitive tests.CONCLUSIONFurthermore, in most of the included studies, it was possible to observe a reduction in inflammatory processes, an increase in the concentration of peptide hormones, insulin homeostasis in the brain, increased antioxidant enzymes, and a decrease in beta-amyloid deposition and tau hyperphosphorylation. Supplementation of probiotics seems to improve performance in cognitive tests and increase the concentration of substances capable of delaying the neurodegenerative process of AD in experimental models.
背景脑肠微生物群(BGM)轴上的条件可显著促进阿尔茨海默病(AD)的发病机制。来自动物研究的证据表明,益生菌通过BGM轴在调节情绪、认知和应激反应中发挥作用。然而,益生菌对AD的影响需要在临床前和临床研究中更好地阐明。方法根据PRISMA编制本系统综述。检索PubMed、Web of Science、Embase和虚拟健康图书馆(VHL)中关于益生菌在实验性AD中的作用的原创文章。结果根据无荟萃分析综合(SWiM)指南作为叙述性综合呈现。17项研究符合纳入标准。结果显示,由于认知测试中的表达改善,单独或混合使用益生菌治疗的AD实验模型具有显著效果。结论此外,在大多数纳入的研究中,可以观察到炎症过程减少,肽激素浓度增加,大脑中胰岛素稳态,抗氧化酶增加,β淀粉样蛋白沉积和tau过度磷酸化减少。在实验模型中,补充益生菌似乎可以提高认知测试的表现,并增加能够延缓AD神经退行性过程的物质的浓度。
{"title":"Effects of supplementation with probiotics in experimental models of Alzheimer's Disease: a systematic review of animal experiments.","authors":"F. Neta, Francisco Emílio Simplício de Souza, André Lima Batista, Francisco Irochima Pinheiro, R. Cobucci, F. Guzen","doi":"10.2174/1567205019666220318092003","DOIUrl":"https://doi.org/10.2174/1567205019666220318092003","url":null,"abstract":"BACKGROUND\u0000Conditions along the brain-gut-microbiota (BGM) axis can significantly contribute to the pathogenesis of Alzheimer's disease (AD). Evidence from animal studies indicates a role for probiotics in regulating mood, cognition, and stress response via the BGM axis. However, the effect of probiotics on AD needs to be better clarified in preclinical and clinical studies.\u0000\u0000\u0000METHOD\u0000We prepared this systematic review according to PRISMA. PubMed, Web of Science, Embase, and Virtual Health Library (VHL) were searched for original articles concerning the effects of probiotics in experimental AD.\u0000\u0000\u0000RESULTS\u0000Results were presented as a narrative synthesis according to the Synthesis Without Meta-analysis (SWiM) Guideline.Seventeen studies met the inclusion criteria. The results showed significant effects in the experimental models of AD treated with probiotics alone or in mixture form due to expressive improvements in cognitive tests.\u0000\u0000\u0000CONCLUSION\u0000Furthermore, in most of the included studies, it was possible to observe a reduction in inflammatory processes, an increase in the concentration of peptide hormones, insulin homeostasis in the brain, increased antioxidant enzymes, and a decrease in beta-amyloid deposition and tau hyperphosphorylation. Supplementation of probiotics seems to improve performance in cognitive tests and increase the concentration of substances capable of delaying the neurodegenerative process of AD in experimental models.","PeriodicalId":10810,"journal":{"name":"Current Alzheimer research","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2022-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46606531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
DEMENTIA COGNITIVE ASSESSMENT: NEED FOR AN INCLUSIVE TOOL DESIGN. 痴呆认知评估:需要一个包容性的工具设计。
IF 2.1 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2022-03-15 DOI: 10.2174/1567205019666220315092008
E. Mukaetova-Ladinska, C. De Lillo, Qadeer Arshad, H. Subramaniam, John J Maltby
{"title":"DEMENTIA COGNITIVE ASSESSMENT: NEED FOR AN INCLUSIVE TOOL DESIGN.","authors":"E. Mukaetova-Ladinska, C. De Lillo, Qadeer Arshad, H. Subramaniam, John J Maltby","doi":"10.2174/1567205019666220315092008","DOIUrl":"https://doi.org/10.2174/1567205019666220315092008","url":null,"abstract":"<jats:sec>\u0000<jats:title />\u0000<jats:p />\u0000</jats:sec>","PeriodicalId":10810,"journal":{"name":"Current Alzheimer research","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2022-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42839911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Dysexecutive Alzheimer's Disease with Lewy Body Disease Co-Pathology. 性功能障碍阿尔茨海默病伴路易体病。
IF 2.1 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2022-03-08 DOI: 10.2174/1567205019666220308152219
Ryan P. Coburn, H. Botha, J. Graff‐Radford, R. Reichard, David T. Jones, V. Ramanan
BACKGROUNDAlzheimer's disease can present atypically as a progressive dysexecutive syndrome (dAD), an entity which preferentially affects younger individuals and is frequently misdiagnosed, highlighting the imperative for additional research.OBJECTIVETo characterize the clinical, antemortem neuroimaging, and postmortem neuropathologic features of two cases of young-onset dAD who displayed evidence of Lewy body disease (LBD) co-pathology at autopsy.METHODSClinical histories, antemortem MRI and PET imaging, and postmortem neuropathologic data were reviewed for each patient. Case Descriptions/Results: Canonical features of dAD were observed in both cases, including progressive and predominant impairment in tasks related to working memory and cognitive flexibility, a lack of major behavioral/personality changes, and evidence of abnormal amyloid and tau deposition by antemortem amyloid and tau PET and postmortem neuropathology. Relative sparing of hippocampal involvement was observed in both individuals, in keeping with many cases of clinically atypical AD. One of the patients developed subtle parkinsonian signs as well as paranoia and irritability in the years prior to passing. In both cases, transitional (brainstem and limbic) LBD co-pathology was observed at autopsy.DISCUSSIONAlthough LBD co-pathology is not uncommon in AD overall, the presence of LBD pathology in these young-onset cases of dAD (including a case with apparent symptomatic correlate) warrants further investigation for broader frequency and underlying pathophysiology.CONCLUSIONA better understanding of which specific young-onset AD phenotypes are associated with LBD co-pathology would have important implications for counseling, treatment, clinical trial enrollment, and knowledge on disease mechanisms.
背景阿尔茨海默病可以非典型地表现为进行性执行障碍综合征(dAD),这种疾病优先影响年轻人,经常被误诊,这突出了进行进一步研究的必要性。目的描述两例年轻发病的dAD患者的临床、生前神经影像学和尸检神经病理学特征,这些患者在尸检中显示出路易体病(LBD)的共同病理学证据。方法回顾每位患者的临床病史、尸检MRI和PET成像以及尸检神经病理学数据。病例描述/结果:在这两个病例中都观察到了dAD的典型特征,包括与工作记忆和认知灵活性相关的任务的进行性和主要损伤,缺乏主要的行为/性格变化,以及通过生前淀粉样蛋白和tau PET以及死后神经病理学发现的淀粉样蛋白异常和tau沉积的证据。两名患者的海马受累相对较少,这与许多临床非典型AD病例一致。其中一名患者在去世前几年出现了微妙的帕金森综合征以及偏执和易怒。在这两个病例中,尸检时都观察到了移行性(脑干和边缘)LBD的共同病理。讨论尽管LBD合并病理在AD中并不罕见,但在这些年轻发病的dAD病例中存在LBD病理(包括具有明显症状相关性的病例),需要进一步研究更广泛的频率和潜在的病理生理学。结论更好地了解哪些特定的年轻发病AD表型与LBD共同病理学相关,将对咨询、治疗、临床试验登记和疾病机制知识具有重要意义。
{"title":"Dysexecutive Alzheimer's Disease with Lewy Body Disease Co-Pathology.","authors":"Ryan P. Coburn, H. Botha, J. Graff‐Radford, R. Reichard, David T. Jones, V. Ramanan","doi":"10.2174/1567205019666220308152219","DOIUrl":"https://doi.org/10.2174/1567205019666220308152219","url":null,"abstract":"BACKGROUND\u0000Alzheimer's disease can present atypically as a progressive dysexecutive syndrome (dAD), an entity which preferentially affects younger individuals and is frequently misdiagnosed, highlighting the imperative for additional research.\u0000\u0000\u0000OBJECTIVE\u0000To characterize the clinical, antemortem neuroimaging, and postmortem neuropathologic features of two cases of young-onset dAD who displayed evidence of Lewy body disease (LBD) co-pathology at autopsy.\u0000\u0000\u0000METHODS\u0000Clinical histories, antemortem MRI and PET imaging, and postmortem neuropathologic data were reviewed for each patient. Case Descriptions/Results: Canonical features of dAD were observed in both cases, including progressive and predominant impairment in tasks related to working memory and cognitive flexibility, a lack of major behavioral/personality changes, and evidence of abnormal amyloid and tau deposition by antemortem amyloid and tau PET and postmortem neuropathology. Relative sparing of hippocampal involvement was observed in both individuals, in keeping with many cases of clinically atypical AD. One of the patients developed subtle parkinsonian signs as well as paranoia and irritability in the years prior to passing. In both cases, transitional (brainstem and limbic) LBD co-pathology was observed at autopsy.\u0000\u0000\u0000DISCUSSION\u0000Although LBD co-pathology is not uncommon in AD overall, the presence of LBD pathology in these young-onset cases of dAD (including a case with apparent symptomatic correlate) warrants further investigation for broader frequency and underlying pathophysiology.\u0000\u0000\u0000CONCLUSION\u0000A better understanding of which specific young-onset AD phenotypes are associated with LBD co-pathology would have important implications for counseling, treatment, clinical trial enrollment, and knowledge on disease mechanisms.","PeriodicalId":10810,"journal":{"name":"Current Alzheimer research","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2022-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44779385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Polymorphism Rs2421943 of the insulin-Degrading Enzyme Gene and the Risk of Late-Onset Alzheimer's Disease. 胰岛素降解酶基因Rs2421943多态性与晚发型阿尔茨海默病的风险
IF 2.1 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2022-03-02 DOI: 10.2174/1567205019666220302120950
O. Šerý, T. Zeman, Alice Hálová, V. Janout, J. Janoutová, J. Lochman, V. Balcar
BACKGROUNDInsulin-degrading enzyme (IDE) is a widely distributed Zn2+-binding metalloprotease that cleaves multiple short and medium-sized peptides prone to form β-structures. These include insulin and amyloid-β peptides. Accumulation and fibrillation of amyloid-β peptides leading to the formation of amyloid plaques is a characteristic sign of Alzheimer's disease (AD) pathology.OBJECTIVEThe study investigated the rs2421943 single nucleotide polymorphism (SNP) of the IDE gene as a risk factor for MCI (Mild cognitive impairment) and AD.METHODSTwo independent groups of 1670 patients and controls were included. The AD group consisted of 595 patients and 400 controls; the MCI group involved 135 patients and 540 matched controls. PCR and restriction fragment length analysis was used for analysis of the rs2421943 polymorphism. Using the miRBase and RNA22 prediction tools in silico indicated that the rs2421943 polymorphism is a potential target for a specific miRNA (hsa-miR-7110-5p).RESULTSAG and GG genotypes of rs2421943 significantly increased the risk of AD and the AG genotype increased the risk of MCI. It seems G allele both increases the risk of AD and accelerates the transition through the MCI phase. In silico study revealed that rs2421943 is inside the sequence binding miRNA hsa-miR-7110-5p. The polymorphism could affect the rate of IDE pre-RNA (heterogeneous nuclear RNA, hnRNA) processing, resulting in slower translation, lower levels of IDE, deficient removal of amyloid-β fragments and greater risk of and/or accelerated progression of AD.CONCLUSIONSGG and AG genotypes of the single nucleotide polymorphism rs2421943 of insulin degrading enzyme gene increase the risk of AD and MCI.
背景胰岛素降解酶(IDE)是一种分布广泛的Zn2+结合金属蛋白酶,可切割多个易于形成β结构的中短肽。其中包括胰岛素和淀粉样蛋白-β肽。淀粉样蛋白-β肽的积累和纤颤导致淀粉样蛋白斑块的形成是阿尔茨海默病(AD)病理学的特征性标志。目的研究IDE基因rs2421943单核苷酸多态性(SNP)作为轻度认知障碍(MCI)和AD的危险因素。方法纳入两个独立的1670名患者和对照组。AD组包括595名患者和400名对照组;MCI组包括135名患者和540名匹配的对照组。应用聚合酶链式反应和限制性片段长度分析方法对rs2421943多态性进行分析。在计算机上使用miRBase和RNA22预测工具表明,rs2421943多态性是特定miRNA(hsa-miR-7110-5p)的潜在靶点。结果rs2421943的GG和GG基因型显著增加AD的风险,AG基因型增加MCI的风险。似乎G等位基因既增加了AD的风险,又加速了MCI期的转变。计算机研究显示rs2421943位于结合miRNA hsa-miR-7110-5p的序列内部。该多态性可能影响IDE前RNA(异质核RNA,hnRNA)处理的速率,导致翻译较慢、IDE水平较低、淀粉样蛋白-β片段去除不足以及AD进展的更大风险和/或加速。结论胰岛素降解酶基因单核苷酸多态性rs2421943的SGG和AG基因型增加了AD和MCI的风险。
{"title":"Polymorphism Rs2421943 of the insulin-Degrading Enzyme Gene and the Risk of Late-Onset Alzheimer's Disease.","authors":"O. Šerý, T. Zeman, Alice Hálová, V. Janout, J. Janoutová, J. Lochman, V. Balcar","doi":"10.2174/1567205019666220302120950","DOIUrl":"https://doi.org/10.2174/1567205019666220302120950","url":null,"abstract":"BACKGROUND\u0000Insulin-degrading enzyme (IDE) is a widely distributed Zn2+-binding metalloprotease that cleaves multiple short and medium-sized peptides prone to form β-structures. These include insulin and amyloid-β peptides. Accumulation and fibrillation of amyloid-β peptides leading to the formation of amyloid plaques is a characteristic sign of Alzheimer's disease (AD) pathology.\u0000\u0000\u0000OBJECTIVE\u0000The study investigated the rs2421943 single nucleotide polymorphism (SNP) of the IDE gene as a risk factor for MCI (Mild cognitive impairment) and AD.\u0000\u0000\u0000METHODS\u0000Two independent groups of 1670 patients and controls were included. The AD group consisted of 595 patients and 400 controls; the MCI group involved 135 patients and 540 matched controls. PCR and restriction fragment length analysis was used for analysis of the rs2421943 polymorphism. Using the miRBase and RNA22 prediction tools in silico indicated that the rs2421943 polymorphism is a potential target for a specific miRNA (hsa-miR-7110-5p).\u0000\u0000\u0000RESULTS\u0000AG and GG genotypes of rs2421943 significantly increased the risk of AD and the AG genotype increased the risk of MCI. It seems G allele both increases the risk of AD and accelerates the transition through the MCI phase. In silico study revealed that rs2421943 is inside the sequence binding miRNA hsa-miR-7110-5p. The polymorphism could affect the rate of IDE pre-RNA (heterogeneous nuclear RNA, hnRNA) processing, resulting in slower translation, lower levels of IDE, deficient removal of amyloid-β fragments and greater risk of and/or accelerated progression of AD.\u0000\u0000\u0000CONCLUSIONS\u0000GG and AG genotypes of the single nucleotide polymorphism rs2421943 of insulin degrading enzyme gene increase the risk of AD and MCI.","PeriodicalId":10810,"journal":{"name":"Current Alzheimer research","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2022-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45103436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Discrepancy between cognitive test and brain imaging results in Alzheimer's disease associated with diabetes. 认知测试与脑成像结果在糖尿病相关的阿尔茨海默病中的差异
IF 2.1 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2022-02-28 DOI: 10.2174/1567205019666220228152655
H. Hanyu, Yumi Koyama, Haruka Horita, Toshinori Aoki, Tomohiko Sato, H. Kanetaka, S. Shimizu, K. Hirao
BACKGROUND/OBJECTIVEAlthough a large number of studies have been performed on the association between Alzheimer's disease (AD) and type 2 diabetes mellitus (DM), the underlying pathophysiology of AD associated with DM has not been fully elucidated to date. We compared cognitive functions and brain imaging findings between AD patients with and without DM to characterize the association between cognition and imaging findings in AD patients with DM.METHODSCognitive functions and brain imaging findings, including medial temporal lobe atrophy analyzed by magnetic resonance imaging, and hypoperfusion in the parietal, posterior cingulate, and frontal regions analyzed by single-photon emission computed tomography were compared between 126 AD patients without DM ([AD-DM]) and 51 AD patients with DM ([AD+DM]). Factors associated with cognitive-imaging associations, including education, occupation, leisure activity, comorbidity, frailty, and other demographics, were analyzed.RESULTSThe [AD+DM] group showed significantly more severe cognitive dysfunction than the [AD- DM] group, despite a similar degree of brain imaging abnormalities. Among the factors associated with cognitive-imaging associations, the level of leisure activity was significantly lower in the [AD+DM] group than in the [AD-DM] group, but no significant differences in other factors were observed between the 2 groups.CONCLUSIONThe cognitive-imaging discrepancy observed in AD patients with DM may be associated with their low cognitive reserve, possibly caused by their low amount of leisure activities. Our findings suggest that lifestyle interventions, including physical, cognitive, and social activities, may reduce cognitive decline in AD patients with DM.
背景/目的尽管已经对阿尔茨海默病(AD)和2型糖尿病(DM)之间的关系进行了大量研究,但迄今为止,AD与DM相关的潜在病理生理学尚未完全阐明。我们比较了患有和不患有糖尿病的AD患者的认知功能和脑影像学表现,以表征患有糖尿病的阿尔茨海默病患者的认知和影像学表现之间的关系。方法认知功能和大脑影像学表现包括磁共振成像分析的内侧颞叶萎缩,以及顶叶、后扣带、,并比较了126例无糖尿病的AD患者([AD-DM])和51例有糖尿病的AD([AD+DM])通过单光子发射计算机断层扫描分析的额叶区域。分析了与认知成像相关的因素,包括教育、职业、休闲活动、共病、虚弱和其他人口统计数据。结果[AD+DM]组表现出比[AD-DM]组更严重的认知功能障碍,尽管脑成像异常程度相似。在与认知成像相关的因素中,[AD+DM]组的休闲活动水平显著低于[AD-DM]组,但两组之间在其他因素上没有观察到显著差异。结论AD合并DM患者的认知影像学差异可能与他们的低认知储备有关,可能是由他们的低休闲活动量引起的。我们的研究结果表明,生活方式干预,包括身体、认知和社交活动,可以减少糖尿病AD患者的认知能力下降。
{"title":"Discrepancy between cognitive test and brain imaging results in Alzheimer's disease associated with diabetes.","authors":"H. Hanyu, Yumi Koyama, Haruka Horita, Toshinori Aoki, Tomohiko Sato, H. Kanetaka, S. Shimizu, K. Hirao","doi":"10.2174/1567205019666220228152655","DOIUrl":"https://doi.org/10.2174/1567205019666220228152655","url":null,"abstract":"BACKGROUND/OBJECTIVE\u0000Although a large number of studies have been performed on the association between Alzheimer's disease (AD) and type 2 diabetes mellitus (DM), the underlying pathophysiology of AD associated with DM has not been fully elucidated to date. We compared cognitive functions and brain imaging findings between AD patients with and without DM to characterize the association between cognition and imaging findings in AD patients with DM.\u0000\u0000\u0000METHODS\u0000Cognitive functions and brain imaging findings, including medial temporal lobe atrophy analyzed by magnetic resonance imaging, and hypoperfusion in the parietal, posterior cingulate, and frontal regions analyzed by single-photon emission computed tomography were compared between 126 AD patients without DM ([AD-DM]) and 51 AD patients with DM ([AD+DM]). Factors associated with cognitive-imaging associations, including education, occupation, leisure activity, comorbidity, frailty, and other demographics, were analyzed.\u0000\u0000\u0000RESULTS\u0000The [AD+DM] group showed significantly more severe cognitive dysfunction than the [AD- DM] group, despite a similar degree of brain imaging abnormalities. Among the factors associated with cognitive-imaging associations, the level of leisure activity was significantly lower in the [AD+DM] group than in the [AD-DM] group, but no significant differences in other factors were observed between the 2 groups.\u0000\u0000\u0000CONCLUSION\u0000The cognitive-imaging discrepancy observed in AD patients with DM may be associated with their low cognitive reserve, possibly caused by their low amount of leisure activities. Our findings suggest that lifestyle interventions, including physical, cognitive, and social activities, may reduce cognitive decline in AD patients with DM.","PeriodicalId":10810,"journal":{"name":"Current Alzheimer research","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2022-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46494825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Impact of Uremic Toxins on Alzheimer's Disease. 尿毒症毒素对阿尔茨海默病的影响。
IF 2.1 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2022-01-01 DOI: 10.2174/1567205019666220120113305
Yuqi Zheng, Bin Ji, Sijun Chen, Rong Zhou, Ruiqing Ni

Alzheimer's disease (AD) is the most common type of dementia, pathologically characterized by the accumulation of senile plaques and neurofibrillary tangles. Chronic kidney disease (CKD) is highly prevalent in the elderly population closely associated with the occurrence of dementia. Recent epidemiological and experimental studies suggest a potential association of CKD with AD. Both diseases share a panel of identical risk factors, such as type 2 diabetes and hypertension. However, the relationship between CKD and AD is unclear. Lower clearance of a panel of uremic toxin including cystatin- C, guanidine, and adiponectin due to CKD is implied to contribute to AD pathogenesis. In this review, we summarize the current evidence from epidemiological, experimental, and clinical studies on the potential contribution of uremic toxins to AD pathogenesis. We describe outstanding questions and propose an outlook on the link between uremic toxins and AD.

阿尔茨海默病(AD)是最常见的痴呆症类型,其病理特征是老年斑和神经原纤维缠结的积累。慢性肾脏疾病(CKD)在老年人群中高度流行,与痴呆的发生密切相关。最近的流行病学和实验研究表明CKD与AD有潜在的联系。这两种疾病都有相同的风险因素,比如2型糖尿病和高血压。然而,CKD与AD之间的关系尚不清楚。CKD导致的一组尿毒症毒素(包括胱抑素- C、胍和脂联素)的清除率较低,可能与AD的发病有关。在这篇综述中,我们总结了目前流行病学、实验和临床研究中关于尿毒症毒素在AD发病中的潜在作用的证据。我们描述了悬而未决的问题,并提出了对尿毒症毒素和AD之间的联系的展望。
{"title":"The Impact of Uremic Toxins on Alzheimer's Disease.","authors":"Yuqi Zheng,&nbsp;Bin Ji,&nbsp;Sijun Chen,&nbsp;Rong Zhou,&nbsp;Ruiqing Ni","doi":"10.2174/1567205019666220120113305","DOIUrl":"https://doi.org/10.2174/1567205019666220120113305","url":null,"abstract":"<p><p>Alzheimer's disease (AD) is the most common type of dementia, pathologically characterized by the accumulation of senile plaques and neurofibrillary tangles. Chronic kidney disease (CKD) is highly prevalent in the elderly population closely associated with the occurrence of dementia. Recent epidemiological and experimental studies suggest a potential association of CKD with AD. Both diseases share a panel of identical risk factors, such as type 2 diabetes and hypertension. However, the relationship between CKD and AD is unclear. Lower clearance of a panel of uremic toxin including cystatin- C, guanidine, and adiponectin due to CKD is implied to contribute to AD pathogenesis. In this review, we summarize the current evidence from epidemiological, experimental, and clinical studies on the potential contribution of uremic toxins to AD pathogenesis. We describe outstanding questions and propose an outlook on the link between uremic toxins and AD.</p>","PeriodicalId":10810,"journal":{"name":"Current Alzheimer research","volume":"19 2","pages":"104-118"},"PeriodicalIF":2.1,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39836758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mild Behavioral Impairment: An Early Sign and Predictor of Alzheimer's Disease Dementia. 轻度行为障碍:阿尔茨海默病痴呆的早期征兆和预测因子。
IF 2.1 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2022-01-01 DOI: 10.2174/1567205019666220805114528
Fei Jiang, Cheng Cheng, Jinsong Huang, Qiaoling Chen, Weidong Le

Background: Alzheimer's disease (AD) is the most common form of dementia in the elderly population and places heavy burdens on medical care and nursing. Recently, the psychiatric and behavioral symptoms of prodromal AD, especially mild behavioral impairment (MBI), have attracted much attention. In 2012, Alzheimer's Association International Conference, MBI was proposed as a syndrome with psychiatric and behavioral disturbance before the onset of typical clinical cognitive symptoms in dementia. Increasing lines of evidence have indicated the link between MBI and early AD pathologies including Aβ and tau.

Objective: This narrative review aims to summarize the advantages of MBI over other concept of psychiatric and behavioral symptoms associated with AD in the early prediction of AD dementia. We also discuss the possible common genetic basis and pathological mechanisms underlying the interactions between MBI and AD.

Methods: Papers cited here were retrieved from PubMed up to February 2022. We selected a total of 95 articles for summary and discussion.

Results: The occurrence of MBI is mainly due to the overlapped genetic and pathological risk factors with AD and is related to the brain's response to environmental stressors. MBI may be a warning sign for the early pathology of AD, and more attention should be paid on the number and duration of MBI symptoms.

Conclusion: MBI may be an early sign and predictor of Alzheimer's disease dementia. Early intervention for MBI may have a positive effect on alleviating long-term cognitive decline.

背景:阿尔茨海默病(AD)是老年人群中最常见的痴呆症,给医疗和护理带来了沉重的负担。近年来,阿尔茨海默病前驱期的精神和行为症状,特别是轻度行为障碍(MBI)引起了人们的广泛关注。在2012年阿尔茨海默病协会国际会议上,MBI被提出为痴呆典型临床认知症状出现前伴有精神和行为障碍的综合征。越来越多的证据表明MBI与包括Aβ和tau在内的早期AD病理之间存在联系。目的:这篇叙述性综述旨在总结MBI相对于其他与AD相关的精神和行为症状概念在AD痴呆早期预测中的优势。我们还讨论了MBI和AD相互作用的可能的共同遗传基础和病理机制。方法:本文引用的论文检索自PubMed截至2022年2月的论文。我们共选取了95篇文章进行总结和讨论。结果:MBI的发生主要是由于遗传和病理危险因素与AD重叠,与大脑对环境应激源的反应有关。MBI可能是AD早期病理的警示信号,MBI症状的出现次数和持续时间应引起更多的关注。结论:MBI可能是阿尔茨海默病痴呆的早期征兆和预测因子。早期干预MBI可能对缓解长期认知能力下降有积极作用。
{"title":"Mild Behavioral Impairment: An Early Sign and Predictor of Alzheimer's Disease Dementia.","authors":"Fei Jiang,&nbsp;Cheng Cheng,&nbsp;Jinsong Huang,&nbsp;Qiaoling Chen,&nbsp;Weidong Le","doi":"10.2174/1567205019666220805114528","DOIUrl":"https://doi.org/10.2174/1567205019666220805114528","url":null,"abstract":"<p><strong>Background: </strong>Alzheimer's disease (AD) is the most common form of dementia in the elderly population and places heavy burdens on medical care and nursing. Recently, the psychiatric and behavioral symptoms of prodromal AD, especially mild behavioral impairment (MBI), have attracted much attention. In 2012, Alzheimer's Association International Conference, MBI was proposed as a syndrome with psychiatric and behavioral disturbance before the onset of typical clinical cognitive symptoms in dementia. Increasing lines of evidence have indicated the link between MBI and early AD pathologies including Aβ and tau.</p><p><strong>Objective: </strong>This narrative review aims to summarize the advantages of MBI over other concept of psychiatric and behavioral symptoms associated with AD in the early prediction of AD dementia. We also discuss the possible common genetic basis and pathological mechanisms underlying the interactions between MBI and AD.</p><p><strong>Methods: </strong>Papers cited here were retrieved from PubMed up to February 2022. We selected a total of 95 articles for summary and discussion.</p><p><strong>Results: </strong>The occurrence of MBI is mainly due to the overlapped genetic and pathological risk factors with AD and is related to the brain's response to environmental stressors. MBI may be a warning sign for the early pathology of AD, and more attention should be paid on the number and duration of MBI symptoms.</p><p><strong>Conclusion: </strong>MBI may be an early sign and predictor of Alzheimer's disease dementia. Early intervention for MBI may have a positive effect on alleviating long-term cognitive decline.</p>","PeriodicalId":10810,"journal":{"name":"Current Alzheimer research","volume":" ","pages":"407-419"},"PeriodicalIF":2.1,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40586826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Application of Diffusion Tensor Imaging Based on Automatic Fiber Quantification in Alzheimer's Disease. 基于纤维自动定量的弥散张量成像在阿尔茨海默病中的应用。
IF 2.1 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2022-01-01 DOI: 10.2174/1567205019666220718142130
Bo Yu, Zhongxiang Ding, Luoyu Wang, Qi Feng, Yifeng Fan, Xiufang Xu, Zhengluan Liao

Background: Neuroimaging suggests that white matter microstructure is severely affected in Alzheimer's disease (AD) progression. However, whether alterations in white matter microstructure are confined to specific regions and whether they can be used as potential biomarkers to distinguish normal control (NC) from AD are unknown.

Methods: In this cross-sectional study, 33 cases of AD and 25 cases of NC were recruited for automatic fiber quantification (AFQ). A total of 20 fiber bundles were equally divided into 100 segments for quantitative assessment of fractional anisotropy (FA), mean diffusivity (MD), volume and curvature. In order to further evaluate the diagnostic value, the maximum redundancy minimum (mRMR) and LASSO algorithms were used to select features, calculate the Radscore of each subject, establish logistic regression models, and draw ROC curves, respectively, to assess the predictive power of four different models.

Results: There was a significant increase in the MD values in AD patients compared with healthy subjects. The differences were mainly located in the left cingulum hippocampus (HCC), left uncinate fasciculus (UF) and superior longitudinal fasciculus (SLF). The point-wise level of 20 fiber bundles was used as a classification feature, and the MD index exhibited the best performance to distinguish NC from AD.

Conclusion: These findings contribute to the understanding of the pathogenesis of AD and suggest that abnormal white matter based on DTI-based AFQ analysis is helpful to explore the pathogenesis of AD.

背景:神经影像学提示阿尔茨海默病(AD)进展中白质微结构受到严重影响。然而,白质微观结构的改变是否局限于特定区域,以及它们是否可以作为区分正常对照(NC)和AD的潜在生物标志物,这些都是未知的。方法:选取33例AD患者和25例NC患者进行自动纤维定量(AFQ)。共20根纤维束被平均分成100段,用于定量评估分数各向异性(FA)、平均扩散率(MD)、体积和曲率。为了进一步评价诊断价值,分别采用最大冗余最小(mRMR)和LASSO算法选择特征,计算每个受试者的Radscore,建立logistic回归模型,绘制ROC曲线,评估四种不同模型的预测能力。结果:AD患者的MD值明显高于健康人。差异主要集中在左扣带海马(HCC)、左钩带束(UF)和上纵束(SLF)。以20个纤维束的点向水平作为分类特征,MD指数对NC和AD的区分效果最好。结论:这些发现有助于了解AD的发病机制,并提示基于dti的AFQ分析异常白质有助于探讨AD的发病机制。
{"title":"Application of Diffusion Tensor Imaging Based on Automatic Fiber Quantification in Alzheimer's Disease.","authors":"Bo Yu,&nbsp;Zhongxiang Ding,&nbsp;Luoyu Wang,&nbsp;Qi Feng,&nbsp;Yifeng Fan,&nbsp;Xiufang Xu,&nbsp;Zhengluan Liao","doi":"10.2174/1567205019666220718142130","DOIUrl":"https://doi.org/10.2174/1567205019666220718142130","url":null,"abstract":"<p><strong>Background: </strong>Neuroimaging suggests that white matter microstructure is severely affected in Alzheimer's disease (AD) progression. However, whether alterations in white matter microstructure are confined to specific regions and whether they can be used as potential biomarkers to distinguish normal control (NC) from AD are unknown.</p><p><strong>Methods: </strong>In this cross-sectional study, 33 cases of AD and 25 cases of NC were recruited for automatic fiber quantification (AFQ). A total of 20 fiber bundles were equally divided into 100 segments for quantitative assessment of fractional anisotropy (FA), mean diffusivity (MD), volume and curvature. In order to further evaluate the diagnostic value, the maximum redundancy minimum (mRMR) and LASSO algorithms were used to select features, calculate the Radscore of each subject, establish logistic regression models, and draw ROC curves, respectively, to assess the predictive power of four different models.</p><p><strong>Results: </strong>There was a significant increase in the MD values in AD patients compared with healthy subjects. The differences were mainly located in the left cingulum hippocampus (HCC), left uncinate fasciculus (UF) and superior longitudinal fasciculus (SLF). The point-wise level of 20 fiber bundles was used as a classification feature, and the MD index exhibited the best performance to distinguish NC from AD.</p><p><strong>Conclusion: </strong>These findings contribute to the understanding of the pathogenesis of AD and suggest that abnormal white matter based on DTI-based AFQ analysis is helpful to explore the pathogenesis of AD.</p>","PeriodicalId":10810,"journal":{"name":"Current Alzheimer research","volume":" ","pages":"469-478"},"PeriodicalIF":2.1,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40517125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Current Alzheimer research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1